{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:53:32Z","timestamp":1793224412951,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203331"],"award-info":[{"award-number":["NIHR203331"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with primary and secondary antibody deficiencies exhibit variable responses to vaccination, with many failing to mount optimal immunity to SARS-CoV-2. Mechanisms underpinning vaccine non-responsiveness remain poorly defined and unpredictable. We hypothesized that B-cell-intrinsic features are associated with SARS-CoV-2 vaccine failure. Peripheral B-cells from 49 patients enrolled in the COVID-19 in Antibody Deficiency (COV-AD) study underwent a validated in vitro B-cell differentiation assay. We assessed plasmablast and plasma cell (PC) generation, immunoglobulin production, immunoglobulin heavy chain (IGH) repertoire diversity, and B-cell activating factor receptor (BAFF-R) expression. Vaccine non-responders displayed reduced IgA class-switched immunoglobulin production in vitro compared with healthy controls (HCs) and responders. Moreover, while the relative percentage of PC output was comparable between groups, the overall number of cells obtained from non-responders was reduced. Most non-responders and a subset of responders exhibited reduced BAFF-R surface expression at baseline compared with HCs, though with considerable overlap between groups. BAFF-R transcript levels partially corresponded with surface expression but varied and did not clearly distinguish response. No compensatory upregulation of alternative B-cell activating factor (BAFF) receptors or elevated serum BAFF was observed. IGH repertoire analysis revealed preserved diversity among patients. Diminished BAFF-R expression is associated with vaccine non-responsiveness and may indicate underlying B-cell-intrinsic defects. BAFF-R shows potential as a candidate biomarker that merits further validation in larger, multicentre cohorts to determine its clinical utility for stratifying patients at risk of vaccine failure. These findings suggest that the BAFF\/BAFF-R axis may play an important role in vaccine-induced humoral immunity in antibody-deficient patients, warranting further mechanistic investigation.<\/jats:p>","DOI":"10.1093\/cei\/uxag004","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T12:28:45Z","timestamp":1768652925000},"source":"Crossref","is-referenced-by-count":1,"title":["BAFF-R expression as a potential biomarker associated with COVID-19 vaccine non-responsiveness in antibody-deficient patients"],"prefix":"10.1093","volume":"220","author":[{"given":"Eleanor","family":"O\u2019Callaghan","sequence":"first","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-2156","authenticated-orcid":false,"given":"Adrian M","family":"Shields","sequence":"additional","affiliation":[{"name":"Clinical Immunology Services, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham , Birmingham ,","place":["UK"]},{"name":"Department of Clinical Immunology, University Hospitals Birmingham National Health Service (NHS) Foundation Trust , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Chang","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Umpierrez","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Newton","sequence":"additional","affiliation":[{"name":"Leeds Institute of Medical Research, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan O","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust , London ,","place":["UK"]},{"name":"Institute of Immunity and Transplantation, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G","family":"Richter","sequence":"additional","affiliation":[{"name":"Clinical Immunology Services, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham , Birmingham ,","place":["UK"]},{"name":"Department of Clinical Immunology, University Hospitals Birmingham National Health Service (NHS) Foundation Trust , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Doody","sequence":"additional","affiliation":[{"name":"Leeds Institute of Medical Research, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7910-0554","authenticated-orcid":false,"given":"Sinisa","family":"Savic","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds ,","place":["UK"]},{"name":"Department of Clinical Immunology and Allergy, St James\u2019s University Hospital , Leeds ,","place":["UK"]},{"name":"NIHR Leeds Biomedical Research Centre , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"2026082614014619600_uxag004-B1","doi-asserted-by":"crossref","first-page":"e100324","DOI":"10.1371\/journal.pone.0100324","article-title":"Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement","volume":"9","author":"Duraisingham","year":"2014","journal-title":"PLoS ONE"},{"key":"2026082614014619600_uxag004-B2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"2026082614014619600_uxag004-B3","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/jcp.2007.051177","article-title":"Antibody deficiency","volume":"61","author":"Herriot","year":"2008","journal-title":"J Clin Pathol"},{"key":"2026082614014619600_uxag004-B4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10875-014-9995-5","article-title":"Antibody deficiency secondary to chronic lymphocytic leukemia: should patients be treated with prophylactic replacement immunoglobulin?","volume":"34","author":"Dhalla","year":"2014","journal-title":"J Clin Immunol"},{"key":"2026082614014619600_uxag004-B5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/cei\/uxac008","article-title":"Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK","volume":"209","author":"Shields","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"2026082614014619600_uxag004-B6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10875-022-01231-7","article-title":"SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study","volume":"42","author":"Shields","year":"2022","journal-title":"J Clin Immunol"},{"key":"2026082614014619600_uxag004-B7","doi-asserted-by":"crossref","first-page":"912571","DOI":"10.3389\/fimmu.2022.912571","article-title":"Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study","volume":"13","author":"Shields","year":"2022","journal-title":"Front Immunol"},{"key":"2026082614014619600_uxag004-B8","first-page":"17651","article-title":"Cryopreservation of primary B cells minimally influences their signaling responses","volume":"8","author":"Hermansen","year":"2018","journal-title":"Nat Sci Rep"},{"key":"2026082614014619600_uxag004-B9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","article-title":"Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal Zone Niches","volume":"20","author":"Thien","year":"2004","journal-title":"Immunity"},{"key":"2026082614014619600_uxag004-B10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"19","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"2026082614014619600_uxag004-B11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"2026082614014619600_uxag004-B12","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"Ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016","edition":"2nd ed"},{"key":"2026082614014619600_uxag004-B13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026082614014619600_uxag004-B14","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"Van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"2026082614014619600_uxag004-B15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/imm.13349","article-title":"Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva","volume":"164","author":"Faustini","year":"2021","journal-title":"Immunology"},{"key":"2026082614014619600_uxag004-B16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.coi.2005.04.005","article-title":"The role of APRIL and BAFF in lymphocyte activation","volume":"17","author":"Schneider","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"2026082614014619600_uxag004-B17","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5","article-title":"Baff is a survival and maturation factor for mouse B cells","volume":"32","author":"Rolink","year":"2024","journal-title":"Eur J Immunol"},{"key":"2026082614014619600_uxag004-B18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1172\/JCI18025","article-title":"Baff selectively enhances the survival of plasmablasts generated from human memory B cells","volume":"112","author":"Avery","year":"2003","journal-title":"J Clin Invest"},{"key":"2026082614014619600_uxag004-B19","doi-asserted-by":"crossref","first-page":"815449","DOI":"10.3389\/fimmu.2022.815449","article-title":"Optimized protocols for in-vitro T-cell-dependent and T-cell-independent activation for B-cell differentiation studies using limited cells","volume":"13","author":"Marsman","year":"2022","journal-title":"Front Immunol"},{"key":"2026082614014619600_uxag004-B20","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.4049\/jimmunol.1103720","article-title":"In vitro generation of long-lived human plasma cells","volume":"189","author":"Cocco","year":"2012","journal-title":"J Immunol"},{"key":"2026082614014619600_uxag004-B21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.1801407","article-title":"Growth factor-like gene regulation is separable from survival and maturation in antibody-secreting cells","volume":"202","author":"Stephenson","year":"2019","journal-title":"J Immunol"},{"key":"2026082614014619600_uxag004-B22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4049\/jimmunol.2100623","article-title":"April drives a coordinated but diverse response as a foundation for plasma cell longevity","volume":"209","author":"Stephenson","year":"2022","journal-title":"J Immunol"},{"key":"2026082614014619600_uxag004-B23","doi-asserted-by":"crossref","first-page":"uxae119","DOI":"10.1093\/cei\/uxae119","article-title":"Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patients","volume":"219","author":"Montamat","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"2026082614014619600_uxag004-B24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiac492","article-title":"Antibody avidity maturation following recovery from infection or the booster vaccination grants breadth of SARS-CoV-2 neutralizing capacity","volume":"227","author":"Nakagama","year":"2023","journal-title":"J Infect Dis"},{"key":"2026082614014619600_uxag004-B25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41408-021-00528-x","article-title":"Antibody responses after first and second covid-19 vaccination in patients with chronic lymphocytic leukaemia","volume":"11","author":"Parry","year":"2021","journal-title":"Blood Cancer J"},{"key":"2026082614014619600_uxag004-B26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imm.12865","article-title":"B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review","volume":"153","author":"Ghraichy","year":"2018","journal-title":"Immunology"},{"key":"2026082614014619600_uxag004-B27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12927","article-title":"Antibody repertoire analysis in polygenic autoimmune diseases","volume":"155","author":"Bashford-Rogers","year":"2018","journal-title":"Immunology"},{"key":"2026082614014619600_uxag004-B28","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.4049\/jimmunol.179.11.7276","article-title":"Regulated expression of BAFF-binding receptors during human B cell differentiation","volume":"179","author":"Darce","year":"2007","journal-title":"J Immunol"},{"key":"2026082614014619600_uxag004-B29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2162-3619-1-36","article-title":"Cd19: a biomarker for B cell development, lymphoma diagnosis and therapy","volume":"1","author":"Wang","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"2026082614014619600_uxag004-B30","doi-asserted-by":"crossref","first-page":"e20191167","DOI":"10.1084\/jem.20191167","article-title":"Baffr controls early memory B cell responses but is dispensable for germinal center function","volume":"218","author":"Lau","year":"2021","journal-title":"J Exp Med"},{"key":"2026082614014619600_uxag004-B31","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3389\/fimmu.2018.02285","article-title":"Baff and BAFF-receptor in B cell selection and survival","volume":"9","author":"Smulski","year":"2018","journal-title":"Front Immunol"},{"key":"2026082614014619600_uxag004-B32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10875-014-0047-y","article-title":"Reduced BAFF-R and increased TACI expression in common variable immunodeficiency","volume":"34","author":"Barbosa","year":"2014","journal-title":"J Clin Immunol"},{"key":"2026082614014619600_uxag004-B33","doi-asserted-by":"crossref","first-page":"13945","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026082614014619600_uxag004-B34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/ard.2006.065656","article-title":"Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary sjogren\u2019s syndrome and systemic lupus erythematosus","volume":"66","author":"Sellam","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2026082614014619600_uxag004-B35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10875-022-01378-3","article-title":"CVID-associated B cell activating factor receptor variants change receptor oligomerization, ligand binding, and signaling responses","volume":"43","author":"Block","year":"2023","journal-title":"J Clin Immunol"},{"key":"2026082614014619600_uxag004-B36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2013.05.007","article-title":"B-cell activating factor (BAFF) is elevated in chronic granulomatous disease","volume":"148","author":"Matharu","year":"2013","journal-title":"Clin Immunol"},{"key":"2026082614014619600_uxag004-B37","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.1600017","article-title":"Cutting edge: BAFF promotes autoantibody production via TACI-dependent activation of transitional B cells","volume":"196","author":"Jacobs","year":"2016","journal-title":"J Immunol"},{"key":"2026082614014619600_uxag004-B38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jaci.2011.05.033","article-title":"Innate immune defects correlate with failure of antibody responses to H1N1\/09 vaccine in HIV-infected patients","volume":"128","author":"Pallikkuth","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2026082614014619600_uxag004-B39","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.celrep.2017.02.005","article-title":"BAFF- and TACI-dependent processing of BAFFR by ADAM proteases regulates the survival of B cells","volume":"18","author":"Smulski","year":"2017","journal-title":"Cell Rep"},{"key":"2026082614014619600_uxag004-B40","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.4161\/cc.9.24.14156","article-title":"Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies","volume":"9","author":"Mihalcik","year":"2010","journal-title":"Cell Cycle"},{"key":"2026082614014619600_uxag004-B41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/hdy.2010.54","article-title":"Epigenetics and gene expression","volume":"105","author":"Gibney","year":"2010","journal-title":"Heredity (Edinb)"},{"key":"2026082614014619600_uxag004-B42","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.molmed.2011.07.005","article-title":"Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases","volume":"17","author":"Hedrich","year":"2011","journal-title":"Trends Mol Med"},{"key":"2026082614014619600_uxag004-B43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fcell.2019.00125","article-title":"Epigenetic priming in immunodeficiencies","volume":"7","author":"Mart\u00ednez-Cano","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"2026082614014619600_uxag004-B44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41590-024-02010-9","article-title":"Disease-associated B-cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE","volume":"26","author":"Faliti","year":"2025","journal-title":"Nat Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxag004\/66487047\/uxag004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag004\/66487047\/uxag004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag004\/66487047\/uxag004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:01:56Z","timestamp":1787767316000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxag004\/8432247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxag004","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"uxag004"}}